Recent research has demonstrated associations between statin use, KIF6 719Arg carrier status, and cholesterol levels and amnestic mild cognitive impairment (aMCI) and Alzheimer's disease (AD) patients. Here, KIF6 is linked to early-onset autosomal dominant Alzheimer disease.